Search research articles
Contact Us
Filters
Showing results (341-350 of 659) with videos related to
Page
of 66
Sort By:
The Journal of Emergency Medicine
|
November 14, 2025
Adapting Evidence-Based Cancer Control Programs for the Emergency Department
Sara W Heinert, Jason J Bischof, Nicholas R Pettit, et al.
Biochemical Pharmacology
|
May 8, 1992
Binding of [3H]bryostatin 4 to protein kinase C
N E Lewin, M L Dell'Aquila, G R Pettit, et al.
Molecular Medicine Reports
|
April 8, 2011
Potentiation of the activity of cisplatin in a human colon tumour xenograft model by auristatin PYE, a structural modification of dolastatin 10
Ekatherine M Prokopiou, Patricia A Cooper, George R Pettit, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Comparison of the antitumor activity of bryostatins 1, 5, and 8
A S Kraft, S Woodley, G R Pettit, et al.
British Journal of Cancer
|
April 1, 1995
The interaction with tubulin of a series of stilbenes based on combretastatin A-4
J A Woods, J A Hadfield, G R Pettit, et al.
Journal of Natural Products
|
January 1, 1990
Antineoplastic agents, 162. Zephyranthes candida
G R Pettit, G M Cragg, S B Singh, et al.
Hematological Oncology
|
March 1, 1990
Conversion of high grade lymphoma tumor cell line to intermediate grade with TPA and bryostatin 1 as determined by polypeptide analysis on 2D gel electrophoresis
A al-Katib, R M Mohammad, A N Mohamed, et al.
Helvetica Paediatrica Acta
|
February 1, 1989
Lactulose in trimethylaminuria, the fish-odour syndrome
M G Pike, G S King, B R Pettit, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 15, 1990
Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin
R Cirillo, M Triggiani, L Siri, et al.
Planta Medica
|
November 27, 2009
Isolation of human cancer cell growth inhibitory, antimicrobial lateritin from a mixed fungal culture
Robin K Pettit, George R Pettit, Jung-Ping Xu, et al.
Page
of 66
Search research articles
Search
Showing results (341-350 of 659) with videos related to
Sort By:
Page
of 66
The Journal of Emergency Medicine
|
November 14, 2025
Adapting Evidence-Based Cancer Control Programs for the Emergency Department
Sara W Heinert, Jason J Bischof, Nicholas R Pettit, et al.
Biochemical Pharmacology
|
May 8, 1992
Binding of [3H]bryostatin 4 to protein kinase C
N E Lewin, M L Dell'Aquila, G R Pettit, et al.
Molecular Medicine Reports
|
April 8, 2011
Potentiation of the activity of cisplatin in a human colon tumour xenograft model by auristatin PYE, a structural modification of dolastatin 10
Ekatherine M Prokopiou, Patricia A Cooper, George R Pettit, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
Comparison of the antitumor activity of bryostatins 1, 5, and 8
A S Kraft, S Woodley, G R Pettit, et al.
British Journal of Cancer
|
April 1, 1995
The interaction with tubulin of a series of stilbenes based on combretastatin A-4
J A Woods, J A Hadfield, G R Pettit, et al.
Journal of Natural Products
|
January 1, 1990
Antineoplastic agents, 162. Zephyranthes candida
G R Pettit, G M Cragg, S B Singh, et al.
Hematological Oncology
|
March 1, 1990
Conversion of high grade lymphoma tumor cell line to intermediate grade with TPA and bryostatin 1 as determined by polypeptide analysis on 2D gel electrophoresis
A al-Katib, R M Mohammad, A N Mohamed, et al.
Helvetica Paediatrica Acta
|
February 1, 1989
Lactulose in trimethylaminuria, the fish-odour syndrome
M G Pike, G S King, B R Pettit, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 15, 1990
Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin
R Cirillo, M Triggiani, L Siri, et al.
Planta Medica
|
November 27, 2009
Isolation of human cancer cell growth inhibitory, antimicrobial lateritin from a mixed fungal culture
Robin K Pettit, George R Pettit, Jung-Ping Xu, et al.
Page
of 66